Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2013-10-24 Interim / Quarterly Rep…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
CellaVision AB: Interim report January - September 2013
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period January 1 to September 30, 2013, covering both the nine-month and third-quarter results. It includes detailed financial statements (Net sales, Operating profit, Profit before tax, Earnings per share), key ratios, management commentary, and analysis of geographical markets. It is not an announcement of a report (RPA) or a simple earnings release (ER), as it provides substantive financial data and analysis typical of an interim/quarterly report. 9M 2013
2013-10-24 English
CellaVision AB: Delårsrapport januari - september 2013
Earnings Release Classification · 1% confidence The document provides detailed financial highlights for the first nine months (Jan-Sep 2013) and the third quarter (Jul-Sep 2013), including net sales, operating results, earnings per share, and balance sheet items. It features comparative figures from the previous year and includes commentary from the CEO. This structure—presenting key financial metrics for a specific reporting period (quarterly and year-to-date) with management discussion—is characteristic of an Interim/Quarterly Report (IR). It is too detailed to be a simple Earnings Release (ER) and is not the full annual filing (10-K). The language is Swedish, but the content clearly maps to a comprehensive interim financial report. 9M 2013
2013-10-24 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is a Swedish-language interim financial report for the period of January 1 to June 30, 2013. It contains detailed financial statements, including net sales, operating results, earnings per share, and liquidity, as well as management's analysis of business trends, geographical market performance, and research and development activities. It is clearly a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2013
2013-07-17 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January - June 2013' and contains comprehensive financial data, including net sales, operating profit, earnings per share, and cash flow for the six-month period ending June 30, 2013. It also includes management commentary, geographical market analysis, and research and development updates. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. H1 2013
2013-07-17 English
CellaVision AB: Interim report January - June 2013
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January - June 2013' and contains comprehensive financial data, including net sales, operating profit, earnings per share, and cash flow for the six-month period ending June 30, 2013. It also includes management commentary, geographical market analysis, and research and development updates. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. H1 2013
2013-07-17 English
CellaVision AB: Delårsrapport januari - juni 2013
Interim / Quarterly Report Classification · 1% confidence The document is a Swedish-language interim financial report for the period of January 1 to June 30, 2013. It contains detailed financial statements, including net sales, operating results, earnings per share, and liquidity, as well as management's analysis of business trends, geographical market performance, and research and development activities. It is clearly a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2013
2013-07-17 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.